Aviv Spinner

Aviv Spinner

Auto-generated profile, based on publicly available information

Aviv Spinner

The Align Foundation

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in Science
Verified
Journal Article
Closed access
GRGordon Rix
Gordon Rix
RWRory L. Williams
Rory L. Williams
VHVincent J. Hu
Vincent J. Hu
ASAviv Spinner
Aviv Spinner
APAlexander (Olek) Pisera
Alexander (Olek) Pisera
CLChang C. Liu
Chang C. Liu
When nature evolves a gene over eons at scale, it produces a diversity of homologous sequences with patterns of conservation and change that contain rich structural, functional, and historical information about the gene. However, natural gene diversity accumulates slowly and likely excludes large regions of functional sequence space, limiting the information that is encoded and extractable. We introduce upgraded orthogonal DNA replication (OrthoRep) systems that radically accelerate the evolution of chosen genes under selection in yeast. When applied to a maladapted biosynthetic enzyme, we obtained collections of extensively diverged sequences with patterns that revealed structural and environmental constraints shaping the enzyme’s activity. Our upgraded OrthoRep systems should support the discovery of factors influencing gene evolution, uncover previously unknown regions of fitness landscapes, and find broad applications in biomolecular engineering.

2 June 2025 in Trends in Biotechnology
Verified
Journal Article
Open access
CBCatherine Baranowski
Catherine Baranowski
HMHector Garcia Martin
Hector Garcia Martin
DODiego A. Oyarzún
Diego A. Oyarzún
ASAviv Spinner
Aviv Spinner
BDBijoy Desai
Bijoy Desai
EDErika A. DeBenedictis
Erika A. DeBenedictis
Recombinant protein expression is central to biotechnology's application. However, not all proteins can be expressed in all organisms, and, given the vast experimental space, it can be challenging to identify the conditions that will yield successful protein expression. The field lacks a predictive model of soluble protein expression that could replace laborious experimental trial and error. Here, we discuss the state of the field and identify the lack of large, high-fidelity datasets as the primary bottleneck to progress. We outline a proposed path toward an extensible experimental platform for collecting soluble overexpression data across organisms. We suggest that the resulting data should be used to train predictive models of protein expression toward answering the question: can protein expression be solved?

12 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CAChase Armer
Chase Armer
HKHassan Kane
Hassan Kane
DCDana L. Cortade
Dana L. Cortade
HRHenning Redestig
Henning Redestig
DEDavid A. Estell
David A. Estell
EDErika DeBenedictis
Erika DeBenedictis
The grand challenge of protein engineering is the development of computational models to characterize and generate protein sequences for arbitrary functions. Progress is limited by lack of 1) benchmarking opportunities, 2) large protein function datasets, and 3) access to experimental protein characterization. We introduce the Protein Engineering Tournament—a fully-remote competition designed to foster the development and evaluation of computational approaches in protein engineering. The tournament consists of an in silico round, predicting biophysical properties from protein sequences, followed by an in vitro round where novel protein sequences are designed, expressed and characterized using automated methods. Upon completion, all datasets, experimental protocols, and methods are made publicly available. We detail the structure and outcomes of a pilot Tournament involving seven protein design teams, powered by six multi-objective datasets, with experimental characterization by our partner, International Flavors and Fragrances. Forthcoming Protein Engineering Tournaments aim to mobilize the scientific community towards transparent evaluation of progress in the field. Graphical

18 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAviv Spinner
Aviv Spinner
SSShwetha Sreenivasan
Shwetha Sreenivasan
JMJames R. McLellan
James R. McLellan
SISvetlana P. Ikonomova
Svetlana P. Ikonomova
DCDana L. Cortade
Dana L. Cortade
SDSimon Doelsnitz
Simon Doelsnitz
Predicting any protein’s function from its sequence alone would be a significant breakthrough in molecular biology. Although machine learning approaches have sought to tackle this, their limited generalizability reflects the absence of sufficiently large, open, diverse, and unified datasets. To address this data gap, we developed a high-throughput experimental platform called GROQ-seq ( Gro wth-based Q uantitative Seq uencing). In GROQ-seq, a protein’s function can be linked to a sequencing-based readout that enables scalable characterization of large variant libraries in Escherichia coli . Here, we present pilot datasets demonstrating its performance across three distinct protein function classes: transcription factors, polymerases, and proteases. The objective of this report is to present the datasets and to provide users with a clear and transparent characterization of their properties, including both the strengths and limitations.

9 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAviv Spinner
Aviv Spinner
DRDavid Ross
David Ross
DCDana Cortade
Dana Cortade
SISvetlana Ikonomova
Svetlana Ikonomova
CBCatherine Baranowski
Catherine Baranowski
CHCorey M. Hudson
Corey M. Hudson
High-throughput functional assays are increasingly used to generate large-scale protein function datasets for protein engineering and machine learning applications. However, the utility of such datasets depends on the reproducibility of the underlying measurements. Here we report reproducible, quantitative measurements of protein sequence-to-function data at scale across two facilities. We analyze GROQ-seq ( G rowth-based Q uantitative Seq uencing) measurements of three bacterial transcription factors. Independent barcode measurements of the same sequence produce highly consistent functional estimates, demonstrating strong biological reproducibility (across all transcription factors the mean Root Mean Square Deviation [RMSD] ≈ 0.53 and mean Spearman ≈ 0.63). We also compared experiments performed at two facilities using a shared protocol, but with differing levels of automation and system integration. We observe strong agreement between measurements taken at the two sites (mean RMSD ≈ 0.41 and mean Spearman ≈ 0.730). Orthogonal tests further support this agreement: a classifier trained to distinguish data by site performs near random (AUC = 0.559), and top-ranking variants show strong statistical overlap between experiments. Together, these results demonstrate that GROQ-seq enables reproducible, scalable measurement of protein function suitable for large aggregated datasets.

12 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CSCourtney A. Shearer
Courtney A. Shearer
RORose Orenbuch
Rose Orenbuch
FTFelix Teufel
Felix Teufel
CSChristian J. Steinmetz
Christian J. Steinmetz
DRDaniel Ritter
Daniel Ritter
DMDebora S. Marks
Debora S. Marks
Disease-associated genetic variants occur extensively in noncoding regions like promoters, but current methods focus primarily on single nucleotide variants (SNVs) that typically have small regulatory effect sizes. Expanding beyond single nucleotide events is essential with insertions and deletions (indels) representing the logical next step as they are readily identifiable in population data and more likely to disrupt regulatory elements. However, existing methods struggle with indel prediction, and clinical interpretation often requires assessing complete promoter haplotypes rather than individual variants. We present LOL-EVE (Language Of Life for Evolutionary Variant Effects), a conditional autoregressive transformer trained on 13.6 million mammalian promoter sequences that enables both zero-shot indel prediction and complete promoter sequence scoring. We introduce three benchmarks for promoter indel prediction: ultra rare variant prioritization, causal eQTL identification, and transcription factor binding site disruption analysis. LOL-EVE’s superior performance demonstrates that evolutionary patterns learned from indels enable accurate assessment of broader promoter function. Application to Genomics England clinical data shows that LOL-EVE can prioritize promoter haplotypes in known developmental disorder genes, suggesting potential utility for clinical variant assessment. LOL-EVE bridges individual variant prediction with haplotype-level analysis, demonstrating how evolution-based genomic language models may assist in evaluating regulatory variants in complex genetic cases.